Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action

被引:84
作者
Menaldino, DS
Bushnev, A
Sun, AM
Liotta, DC
Symolon, H
Desai, K
Dillehay, DL
Peng, Q
Wang, E
Allegood, J
Trotman-Pruett, S
Sullards, MC
Merrill, AH [1 ]
机构
[1] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA
[3] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
[4] Emory Univ, Div Anim Resources, Atlanta, GA 30322 USA
[5] Emory Univ, Div Biol & Biomed Sci, Atlanta, GA 30322 USA
[6] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
关键词
sphingoid base; sphingolipid; fumonisins; toxicity; cancer;
D O I
10.1016/S1043-6618(03)00054-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The sphingoid base backbones of sphingolipids (sphingosines, sphinganines, 4-hydroxysphinganines and others) are highly bioactive species directly and-in most cases-as their metabolites, the N-acyl-sphingoid bases (ceramides) and sphingoid base 1-phosphates. The complexity of these compounds affords many opportunities to prepare synthetic analogs for studies of sphingolipid metabolism and the functions of the sphingoid bases and metabolites. Described in this review are methods for the preparation of libraries of sphingoid bases, including a series of 1-deoxy-analogs, as well as information about their metabolism and biological activities. Findings with these compounds have uncovered some of the complications of working with compounds that mimic a naturally occurring biomodulator-such as that they are sometimes metabolized by enzymes that handle the endogenous compounds and the products may have potent (and unexpected) biological activities. Through studying such compounds, there is now a greater understanding of the metabolism and mechanism(s) of action of naturally occurring sphingoid bases as well as of these analogs. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 42 条
[1]   Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and N-acetylsphingosine [J].
Birt, DF ;
Merrill, AH ;
Barnett, T ;
Enkvetchakul, B ;
Pour, PM ;
Liotta, DC ;
Geisler, V ;
Menaldino, DS ;
Schwartzbauer, J .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (02) :119-126
[2]  
BUEHRER BM, 1992, J BIOL CHEM, V267, P3154
[3]  
Chester MA, 1998, EUR J BIOCHEM, V257, P293
[4]  
Curfman C, 2000, METHOD ENZYMOL, V311, P391
[5]   Sphingosine in apoptosis signaling [J].
Cuvillier, O .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1585 (2-3) :153-162
[6]   Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis [J].
Desai, K ;
Sullards, MC ;
Allegood, J ;
Wang, E ;
Schmelz, EM ;
Hartl, M ;
Humpf, HU ;
Liotta, DC ;
Peng, Q ;
Merrill, AH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1585 (2-3) :188-192
[7]   INHIBITION OF THE INDUCTION OF ORNITHINE DECARBOXYLASE ACTIVITY BY 12-O-TETRADECANOYLPHORBOL-13-ACETATE IN MOUSE SKIN BY SPHINGOSINE SULFATE [J].
ENKVETCHAKUL, B ;
MERRILL, AH ;
BIRT, DF .
CARCINOGENESIS, 1989, 10 (02) :379-381
[8]   INFLUENCES OF SPHINGOSINE ON 2-STAGE SKIN TUMORIGENESIS IN SENCAR MICE [J].
ENKVETCHAKUL, B ;
BARNETT, T ;
LIOTTA, DC ;
GEISLER, V ;
MENALDINO, D ;
MERRILL, AH ;
BIRT, DF .
CANCER LETTERS, 1992, 62 (01) :35-42
[9]   A STEREODIVERGENT SYNTHESIS OF D-ERYTHRO-SPHINGOSINE AND D-THREO-SPHINGOSINE FROM L-SERINE [J].
GARNER, P ;
PARK, JM ;
MALECKI, E .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (18) :4395-4398
[10]   ALDOL REACTIONS OF ALPHA-(N,N-DIBENZYLAMINO) ETHYL KETONES [J].
GOH, JB ;
LAGU, BR ;
WURSTER, J ;
LIOTTA, DC .
TETRAHEDRON LETTERS, 1994, 35 (33) :6029-6032